Copyright Reports & Markets. All rights reserved.

Global Selective Agonists Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Selective Agonists Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Selective Agonists Market Size 2014-2024
        • 2.1.2 Selective Agonists Market Size CAGR by Region
      • 2.2 Selective Agonists Segment by Type
        • 2.2.1 α1 Selective Agonists
        • 2.2.2 α2 Selective Agonists
        • 2.2.3 β1 Selective Agonists
        • 2.2.4 β2 Selective Agonists
      • 2.3 Selective Agonists Market Size by Type
        • 2.3.1 Global Selective Agonists Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Selective Agonists Market Size Growth Rate by Type (2014-2019)
      • 2.4 Selective Agonists Segment by Application
        • 2.4.1 Paroxysmal Supraventricular Tachycardia
        • 2.4.2 Eye Drops
        • 2.4.3 Anaphylaxis
        • 2.4.4 Cardiac Arrest
        • 2.4.5 Anaphylaxis
        • 2.4.6 Cardiac Arrest
        • 2.4.7 Chronic Heart Failure
        • 2.4.8 Myocardial Infarction
        • 2.4.9 Postoperative Hypotension
        • 2.4.10 Others
      • 2.5 Selective Agonists Market Size by Application
        • 2.5.1 Global Selective Agonists Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Selective Agonists Market Size Growth Rate by Application (2014-2019)

      3 Global Selective Agonists by Players

      • 3.1 Global Selective Agonists Market Size Market Share by Players
        • 3.1.1 Global Selective Agonists Market Size by Players (2017-2019)
        • 3.1.2 Global Selective Agonists Market Size Market Share by Players (2017-2019)
      • 3.2 Global Selective Agonists Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Selective Agonists by Regions

      • 4.1 Selective Agonists Market Size by Regions
      • 4.2 Americas Selective Agonists Market Size Growth
      • 4.3 APAC Selective Agonists Market Size Growth
      • 4.4 Europe Selective Agonists Market Size Growth
      • 4.5 Middle East & Africa Selective Agonists Market Size Growth

      5 Americas

      • 5.1 Americas Selective Agonists Market Size by Countries
      • 5.2 Americas Selective Agonists Market Size by Type
      • 5.3 Americas Selective Agonists Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Selective Agonists Market Size by Countries
      • 6.2 APAC Selective Agonists Market Size by Type
      • 6.3 APAC Selective Agonists Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Selective Agonists by Countries
      • 7.2 Europe Selective Agonists Market Size by Type
      • 7.3 Europe Selective Agonists Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Selective Agonists by Countries
      • 8.2 Middle East & Africa Selective Agonists Market Size by Type
      • 8.3 Middle East & Africa Selective Agonists Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Selective Agonists Market Forecast

      • 10.1 Global Selective Agonists Market Size Forecast (2019-2024)
      • 10.2 Global Selective Agonists Forecast by Regions
        • 10.2.1 Global Selective Agonists Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Selective Agonists Forecast by Type
      • 10.8 Global Selective Agonists Forecast by Application

      11 Key Players Analysis

      • 11.1 Merck
        • 11.1.1 Company Details
        • 11.1.2 Selective Agonists Product Offered
        • 11.1.3 Merck Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Merck News
      • 11.2 Bausch Health Companies
        • 11.2.1 Company Details
        • 11.2.2 Selective Agonists Product Offered
        • 11.2.3 Bausch Health Companies Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Bausch Health Companies News
      • 11.3 Pfizer
        • 11.3.1 Company Details
        • 11.3.2 Selective Agonists Product Offered
        • 11.3.3 Pfizer Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Pfizer News
      • 11.4 Sterling Winthrop
        • 11.4.1 Company Details
        • 11.4.2 Selective Agonists Product Offered
        • 11.4.3 Sterling Winthrop Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Sterling Winthrop News
      • 11.5 Sanofi
        • 11.5.1 Company Details
        • 11.5.2 Selective Agonists Product Offered
        • 11.5.3 Sanofi Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Sanofi News
      • 11.6 Paragon BioTeck
        • 11.6.1 Company Details
        • 11.6.2 Selective Agonists Product Offered
        • 11.6.3 Paragon BioTeck Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Paragon BioTeck News
      • 11.7 West-Ward Pharmaceuticals
        • 11.7.1 Company Details
        • 11.7.2 Selective Agonists Product Offered
        • 11.7.3 West-Ward Pharmaceuticals Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 West-Ward Pharmaceuticals News
      • 11.8 Biosyent Pharma
        • 11.8.1 Company Details
        • 11.8.2 Selective Agonists Product Offered
        • 11.8.3 Biosyent Pharma Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Biosyent Pharma News
      • 11.9 Novartis
        • 11.9.1 Company Details
        • 11.9.2 Selective Agonists Product Offered
        • 11.9.3 Novartis Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Novartis News
      • 11.10 Omega Laboratories
        • 11.10.1 Company Details
        • 11.10.2 Selective Agonists Product Offered
        • 11.10.3 Omega Laboratories Selective Agonists Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Omega Laboratories News
      • 11.11 Medical Purchasing Solutions
      • 11.12 Avadel Legacy Pharmaceuticals
      • 11.13 Amneal Biosciences
      • 11.14 Cipla USA
      • 11.15 Par Pharmaceutical
      • 11.16 Glaxosmithkline
      • 11.17 Teva
      • 11.18 Bayer
      • 11.19 Impax Generics
      • 11.20 Mylan Pharmaceuticals
      • 11.21 Physicians Total Care
      • 11.22 Cadila Pharnmaceuticals
      • 11.23 Alembic Pharmaceuticals
      • 11.24 Allergan
      • 11.25 Mylan

      12 Research Findings and Conclusion

      According to this study, over the next five years the Selective Agonists market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Selective Agonists business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Selective Agonists market by product type, application, key companies and key regions.

      This study considers the Selective Agonists value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      α1 Selective Agonists
      α2 Selective Agonists
      β2 Selective Agonists
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Paroxysmal Supraventricular Tachycardia
      Eye Drops
      Anaphylaxis
      Cardiac Arrest
      Anaphylaxis
      Cardiac Arrest
      Chronic Heart Failure
      Myocardial Infarction
      Postoperative Hypotension
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Merck
      Bausch Health Companies
      Pfizer
      Sterling Winthrop
      Sanofi
      Paragon BioTeck
      West-Ward Pharmaceuticals 
      Biosyent Pharma 
      Novartis
      Omega Laboratories
      Medical Purchasing Solutions
      Avadel Legacy Pharmaceuticals
      Amneal Biosciences
      Cipla USA
      Par Pharmaceutical
      Glaxosmithkline
      Teva
      Bayer
      Impax Generics
      Mylan Pharmaceuticals
      Physicians Total Care
      Cadila Pharnmaceuticals
      Alembic Pharmaceuticals
      Allergan
      Mylan

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Selective Agonists market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Selective Agonists market by identifying its various subsegments.
      Focuses on the key global Selective Agonists players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Selective Agonists with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Selective Agonists submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now